Market Research Logo

United States Bariatric Surgery Devices Market Outlook to 2023

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Bariatric Surgery Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Bariatric Surgery Devices Market, United States
3.1 Bariatric Surgery Devices Market, United States, Revenue ($m), 2009-2016
3.2 Bariatric Surgery Devices Market, United States, Revenue ($m), 2016-2023
3.3 Bariatric Surgery Devices Market, United States, Volume (Units), 2009-2016
3.4 Bariatric Surgery Devices Market, United States, Volume (Units), 2016-2023
3.5 Bariatric Surgery Devices Market, United States, Average Price ($), 2009-2023
3.6 Bariatric Surgery Devices Market, United States, Distribution Share by Revenue ($m), 2016
3.7 Bariatric Surgery Devices Market, United States, Company Share by Revenue ($m), 2016
4 Overview of Key Companies in United States, Bariatric Surgery Devices Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Ethicon Inc
4.2.1 Company Overview
4.3 Apollo Endosurgery Inc
4.3.1 Company Overview
5 Bariatric Surgery Devices Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Allergan to Acquire Zeltiq Aesthetics for USD2.48 Billion
6.1.2 Confluent Medical Technologies Acquires ETE Medical
6.2 Equity Offerings
6.2.1 EnteroMedics Raises USD19 Million in Public Offering of Units
6.2.2 TransEnterix Plans to Raise up to USD25 Million in Private Placement of Shares
6.2.3 GI Dynamics to Raise up to USD0.7 Million in Security Purchase Plan of CDIs
6.2.4 Obalon Therapeutics Prices IPO for USD75 Million
6.3 Venture Financing
6.3.1 Reshape Medical Raises USD11 Million in Venture Financing
6.3.2 Allurion Tech Raises USD19 Million in Venture Financing
6.3.3 MetaModix Raises USD0.1 Million in Venture Financing
6.3.4 Standard Bariatrics Raises Funds through Seed Financing
6.3.5 Aspire Bariatrics Raises USD3.6 Million in Venture Financing
6.3.6 MetaModix Raises USD0.1 Million in Financing
7 Recent Developments
7.1 Corporate Communications
7.1.1 Jan 17, 2017: Apollo Endosurgery Appoints Dr. Christopher J. Gostout as Chief Medical Officer
7.1.2 Jan 17, 2017: Jonah Shacknai Joins Obalon Therapeutics Board of Directors
7.1.3 Jan 09, 2017: ZELTIQ Aesthetics Announces Commercial Leadership Transition
7.1.4 Jan 05, 2017: GI Dynamics Appoints Oern R. Stuge, MD, Amid Change to Company’s Board of Directors
7.1.5 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer
7.1.6 Sep 27, 2016: EnteroMedics Announces Appointment of Dan Gladney as Chairman of the Board of Directors
7.1.7 Sep 07, 2016: EnteroMedics Announces Appointment of Scott Youngstrom as Chief Financial Officer and Chief Compliance Officer
7.1.8 Sep 02, 2016: Gelesis Appoints New Chief Operating Officer
7.1.9 Aug 22, 2016: Vizient Announces Aaron Gerber, M.D. as the Newly Appointed President of Sg2
7.1.10 Aug 22, 2016: Vizient Announces Aaron Gerber, M.D. as the Newly Appointed President of Sg2
7.1.11 Aug 17, 2016: EnteroMedics Announces Appointment of Gary Blackford to its Board of Directors
7.1.12 Aug 08, 2016: ReShape Medical Announces the Appointment of Michael J. Mangano as President and Chief Executive Officer
7.1.13 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors
7.1.14 Jun 27, 2016: Vizient Announces New Members to its Board of Directors
7.1.15 May 25, 2016: TransEnterix Appoints Theodore Pappas, MD Senior Surgical Officer
7.1.16 May 10, 2016: GI Dynamics Appoints Chief Compliance Officer
7.1.17 May 05, 2016: GI Dynamics Appoints Chief Financial Officer
7.1.18 May 04, 2016: BAROnova Announces Appointment of David S. Thrower as President and Chief Executive Officer
7.1.19 May 03, 2016: GI Dynamics: Daniel J. Moore Elected Chairman of the Board
7.1.20 Apr 26, 2016: Hospira President, David J. Endicott, Joins ZELTIQ Aesthetics Board of Directors
7.1.21 Mar 23, 2016: GI Dynamics Announces the Appointment of Medical Device Industry Veteran Scott Schorer as President & Chief Executive Officer
7.2 Financial Announcements
7.2.1 Feb 23, 2017: Obalon Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results
7.2.2 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016
7.2.3 Jan 31, 2017: GI Dynamics: Quarterly Report - Quarter Ended 31 December 2016
7.2.4 Jan 26, 2017: Bard Announces Fourth Quarter Results
7.2.5 Jan 09, 2017: ZELTIQ Reports Preliminary Fourth Quarter and Full Year 2016 Revenue and Provides 2017 Guidance
7.2.6 Nov 11, 2016: Obalon Therapeutics Announces Third Quarter Financial Results
7.2.7 Nov 09, 2016: TransEnterix Reports Operating Results for the Third Quarter 2016
7.2.8 Nov 09, 2016: ZELTIQ Announces Third Quarter 2016 Financial Results
7.2.9 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016
7.2.10 Oct 25, 2016: Bard Announces Third Quarter Results
7.2.11 Aug 08, 2016: ZELTIQ Announces Second Quarter 2016 Financial Results
7.2.12 Aug 05, 2016: TransEnterix Reports Operating Results for the Second Quarter 2016
7.2.13 Aug 04, 2016: EnteroMedics Reports Second Quarter 2016 Financial Results
7.2.14 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016
7.2.15 Jul 28, 2016: GI Dynamics: Appendix 4C: Quarter ended 30 June 2016
7.2.16 Jul 26, 2016: Bard Announces Second Quarter Results
7.2.17 May 10, 2016: TransEnterix Reports Operating Results for the First Quarter 2016
7.2.18 May 10, 2016: ZELTIQ Announces First Quarter 2016 Financial Results
7.3 Other Significant Developments
7.3.1 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
7.3.2 Jan 24, 2017: Mayo Clinic Selects Vizient as Its Performance Improvement Partner
7.3.3 Jan 11, 2017: GI Dynamics Provides 2017 Business Outlook and 2016 Review
7.3.4 Nov 22, 2016: EnteroMedics Provides Commercialization and Corporate Update
7.3.5 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation
7.3.6 May 02, 2016: EnteroMedics Announces Exclusive Federal Government Business Channel Sales Agreement with Academy Medical to Provide vBloc Neurometabolic Therapy
7.3.7 Apr 07, 2016: Response Biomedical Awarded Capital Equipment Supplier Contract by Vizient
7.4 Product News
7.4.1 Feb 09, 2017: EnteroMedics Announces Publication of Three-Year Data from vBloc Diabetic Patient Study in Journal of Diabetes and Obesity
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
7.1.7 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
1.1 List of Tables
Table 1: Bariatric Surgery Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 2: Bariatric Surgery Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 3: Bariatric Surgery Devices Market, United States, Volume (Units), Historic, 2009-2016
Table 4: Bariatric Surgery Devices Market, United States, Volume (Units), Forecast, 2016-2023
Table 5: Bariatric Surgery Devices Market, United States, Average Price ($), Historic, 2009-2016
Table 6: Bariatric Surgery Devices Market, United States, Average Price ($), Forecast, 2016-2023
Table 7: Bariatric Surgery Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2016
Table 8: Bariatric Surgery Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2016
Table 9: Bariatric Surgery Devices Market Pipeline Products
Table 10: Allergan to Acquire Zeltiq Aesthetics for USD2.48 Billion
Table 11: Confluent Medical Technologies Acquires ETE Medical
Table 12: EnteroMedics Raises USD19 Million in Public Offering of Units
Table 13: TransEnterix Plans to Raise up to USD25 Million in Private Placement of Shares
Table 14: GI Dynamics to Raise up to USD0.7 Million in Security Purchase Plan of CDIs
Table 15: Obalon Therapeutics Prices IPO for USD75 Million
Table 16: Reshape Medical Raises USD11 Million in Venture Financing
Table 17: Allurion Tech Raises USD19 Million in Venture Financing
Table 18: MetaModix Raises USD0.1 Million in Venture Financing
Table 19: Standard Bariatrics Raises Funds through Seed Financing
Table 20: Aspire Bariatrics Raises USD3.6 Million in Venture Financing
Table 21: MetaModix Raises USD0.1 Million in Financing
Table 22: Total Number of Primary Research Participants, General Surgery Market, by Country
1.2 List of Figures
Figure 1: Bariatric Surgery Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 2: Bariatric Surgery Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 3: Bariatric Surgery Devices Market, United States, Volume (Units), Historic, 2009-2016
Figure 4: Bariatric Surgery Devices Market, United States, Volume (Units), Forecast, 2016-2023
Figure 5: Bariatric Surgery Devices Market, United States, Company Share (%) 2016

United States Bariatric Surgery Devices Market Outlook to 2023

Summary

GlobalData’s new report, United States Bariatric Surgery Devices Market Outlook to 2023, provides key market data on the United States Bariatric Surgery Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Bariatric Stapling Devices, Gastric Bands and Gastric Balloons.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Bariatric Surgery Devices market segments - Bariatric Stapling Devices, Gastric Bands and Gastric Balloons.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the United States Bariatric Surgery Devices market.
  • Key players covered include Medtronic plc, Ethicon Inc and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;